HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Sebaceous Cell Carcinoma

Sebaceous Cell Carcinoma

Sebaceous cell carcinoma (SCC) is a rare and aggressive form of skin cancer originating in the sebaceous glands. Although it represents only a small fraction of skin malignancies, its tendency to metastasize makes it a significant health concern. Research on SCC primarily focuses on early detection methods and effective treatments to improve patient outcomes. Recent advancements in genomic analysis have shed light on the genetic mutations driving SCC development, paving the way for targeted therapies. Additionally, immunotherapies and photodynamic therapy are being explored as promising treatment modalities. Collaborative efforts among clinicians, researchers, and pharmaceutical companies aim to unravel the complexities of SCC biology and develop personalized treatment approaches for better management of this challenging disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp